Multi-center, Randomized, Double Blinded, Placebo-controlled, Phase II Trial to Assess the Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation

Trial Profile

Multi-center, Randomized, Double Blinded, Placebo-controlled, Phase II Trial to Assess the Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Jun 2015

At a glance

  • Drugs Relenopride (Primary)
  • Indications Irritable bowel syndrome
  • Focus Therapeutic Use
  • Acronyms YKP
  • Sponsors SK Chemicals
  • Most Recent Events

    • 11 Jun 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 13 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top